Newton R, Ribeiro T, Casabonne D, Alvarez E, Touzé A, Key T, Coursaget P
Epidemiology & Genetics Unit, Department of Health Sciences, Heslington, York, UK.
Br J Cancer. 2005 Nov 28;93(11):1305-6. doi: 10.1038/sj.bjc.6602869.
In a case-control study nested within the EPIC-Oxford cohort, there were no statistically significant differences in the prevalence or titre of antibodies against BK virus measured in plasma taken prior to diagnosis between cases with cancer of the prostate (n=31), kidney (n=5) or bladder (n=9) and controls (n=45).
在一项嵌套于EPIC - 牛津队列中的病例对照研究中,在前列腺癌(n = 31)、肾癌(n = 5)或膀胱癌(n = 9)患者及对照组(n = 45)诊断前采集的血浆中,检测到的抗BK病毒抗体的患病率或滴度在统计学上无显著差异。